RxSight, Inc. (NASDAQ: RXST) reported Q4 EPS of ($0.03), $0.32 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $32.6 million versus the consensus estimate of $28.11 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.